Art

J-GLOBAL ID：201702230437631316   Reference number：17A0701350

A case of glioblastoma resected immediately after administering bevacizumab: consideration on histopathological findings and safety of surgery

ベバシズマブ投与直後に切除した神経膠芽腫の症例:組織病理学的所見および手術の安全性についての考察

Clips

Author (5)： TOKUDA Yukina (Keio Univ. Hospital, Tokyo, JPN) ,  TAMURA Ryota (Keio Univ. Hospital, Tokyo, JPN) ,  OHARA Kentaro (Keio Univ. Hospital, Tokyo, JPN) ,  YOSHIDA Kazunari (Keio Univ. Hospital, Tokyo, JPN) ,  SASAKI Hikaru (Keio Univ. Hospital, Tokyo, JPN)
Material： Brain Tumor Pathology  (Brain Tumor Pathol)
Volume： 34  Issue： 2  Page： 98-102  Publication year： 2017 
JST Material Number： L2617A  ISSN： 1433-7398  Document type： Article
Article type： 短報  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： Bevacizumab ,...

Register(free) or Log In to access     To see more with JDream III (charged).  

JST classification (2)： Tumors(=neoplasms)of nervous system  (GN04000V) ,  Treatment for tumors in general  (GE03031L)

Substance index (1)： Temozolomide

Reference (12)：

• Chinot OL, Wick W, Mason W et al (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370:709-722. doi:10.1056/NEJMoa1308345
• Gilbert MR, Dignam JJ, Armstrong TS et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699-708. doi:10.1056/NEJMoa1308573
• Di G, Hl C, Kr G et al (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2(10):1096-1103
• Jain RK, di Tomaso E, Duda DG et al (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610. doi:10.1038/NRN2175
• Tamura R, Tanaka T, Miyake K et al (2016) Histopathological investigation of glioblastomas resected under bevacizumab treatment. Oncotarget 7(32):52423-52435

Terms in the title (8)： ベバシズマブ ,  投与 ,  神経膠芽腫 ,  症例 ,  組織 ,  病理学的所見 ,  手術 ,  安全性